Woburn, Massachusetts, USA
May 14, 2020
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company has secured all of the regulatory permits required to conduct field tests for multiple traits at sites in the United States and Canada contracted for the 2020 growing season. Yield10’s 2020 Field Test Program will evaluate several novel traits in Camelina and canola. Planting is expected to begin in second quarter 2020 pending suitable weather conditions.
Yield10 utilizes the oilseed plant Camelina sativa to rapidly evaluate the activity of novel performance traits for development in Camelina as well as for licensing in key commercial crops, including canola, soybean, corn and other crops. Yield10 is also developing Camelina as a platform crop for developing and commercializing traits to produce nutritional oils and PHA biomaterials. Yield10’s expertise and development activities in oilseed crops extends to canola, where the Company is deploying novel yield traits and developing lines for crossing into elite, commercial varieties of canola.
“The 2020 Field Test Program will be our largest to date in terms of the number of traits we will test and the number of field test sites involved in the U.S. and Canada,” said Dr. Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience. “Our team worked very closely with crop regulatory authorities in the U.S. (USDA-APHIS) and Canada (CFIA) to secure the permits allowing shipment of seed to our contracted field test sites, marking a major milestone for Yield10 as we prepare for planting in the weeks ahead. Our field tests are designed to generate data that will support our ongoing development efforts for our traits in Camelina, canola and other commercial crops.”
A summary of the 2020 Field Test Program:
- Camelina/C3004: C3004 is a trait designed to increase seed yield that has shown promise in previous greenhouse and growth chamber experiments.
- Camelina/CRISPR E3902: E3902 is a CRISPR genome-edited trait designed to boost oil content. This line gave positive results in 2019 field tests.
- Camelina/CRISPR C3007: C3007 is a CRISPR genome-edited trait designed to boost oil content. This is the first season field testing the trait.
- Camelina/C3014 and C3015 :Yield10 has designed a novel trait and reprogrammed Camelina to produce PHA biomaterial as a third seed product. This is the first season field testing the trait.
- Canola/C3004: C3004 is a trait designed to increase seed yield. This is the first season field testing the trait in canola.
- Canola/C3003: Yield10 will grow 14 new canola/C3003 commercial quality lines for seed bulk up in the field in 2020 and plans to field test to measure performance of these lines in 2021. C3003 is a seed yield trait.
In the field tests of its novel traits in Camelina and canola, Yield10 will monitor key agronomic and growth parameters of the plants throughout the growth period. Yield10 also plans to evaluate seed yield, oil content, PHA content and/or other parameters of the traits as appropriate after seed harvest. The program will also generate field grown seed for subsequent field studies. The field tests are designed to generate data on the activity of the novel traits and to advance the development of the traits toward commercialization.
Topics
Species
